Aga Khan University Begins Mix-And-Match COVID-19 Vaccine Study
November 23, 2021
November 23, 2021
KARACHI, Pakistan, Nov. 23 (TNSRes) -- Aga Khan University issued the following news release:
The Coalition for Epidemic Preparedness Innovations (CEPI) and the Aga Khan University (AKU) today announced a new collaboration to conduct a clinical trial of heterologous - or 'mix-and-match' - combinations of COVID-19 vaccines in Pakistan. CEPI will provide up to US$ 11.7 million of funding for the project to an international consortium led by AKU, comprising the National Institute of He . . .
The Coalition for Epidemic Preparedness Innovations (CEPI) and the Aga Khan University (AKU) today announced a new collaboration to conduct a clinical trial of heterologous - or 'mix-and-match' - combinations of COVID-19 vaccines in Pakistan. CEPI will provide up to US$ 11.7 million of funding for the project to an international consortium led by AKU, comprising the National Institute of He . . .